{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:14:46Z","timestamp":1794060886950,"version":"4.8.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41587-025-02711-y","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T05:03:40Z","timestamp":1750914220000},"page":"810-818","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Lipid nanoparticle screening in nonhuman primates with minimal loss of life"],"prefix":"10.1038","volume":"44","author":[{"given":"Ryan","family":"Zenhausern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Schrader Echeverri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Gentry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth H.","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle L.","family":"Stammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Loughrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanthi","family":"Chappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Koveal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7937-2733","authenticated-orcid":false,"given":"Hyejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7580-436X","authenticated-orcid":false,"given":"James E.","family":"Dahlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"2711_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams, D. et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 379, 11\u201321 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2711_CR2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2711_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2020","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2711_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore, J. D. et al. CRISPR\u2013Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493\u2013502 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2711_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJMoa2309149","volume":"390","author":"HJ Longhurst","year":"2024","unstructured":"Longhurst, H. J. et al. CRISPR\u2013Cas9 in vivo gene editing of KLKB1 for hereditary angioedema. N. Engl. J. Med. 390, 432\u2013441 (2024).","journal-title":"N. Engl. J. Med."},{"key":"2711_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41565-023-01563-4","volume":"19","author":"J Kim","year":"2024","unstructured":"Kim, J., Eygeris, Y., Ryals, R. C., Jozi\u0107, A. & Sahay, G. Strategies for non-viral vectors targeting organs beyond the liver. Nat. Nanotechnol. 19, 428\u2013447 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"2711_CR7","doi-asserted-by":"publisher","first-page":"12181","DOI":"10.1021\/acs.chemrev.1c00244","volume":"121","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Sun, C., Wang, C., Jankovic, K. E. & Dong, Y. Lipids and lipid derivatives for RNA delivery. Chem. Rev. 121, 12181\u201312277 (2021).","journal-title":"Chem. Rev."},{"key":"2711_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.66","volume":"2","author":"BL Mui","year":"2013","unstructured":"Mui, B. L. et al. Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles. Mol. Ther. Nucleic Acids 2, e139 (2013).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2711_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42189-3","volume":"14","author":"M Gautam","year":"2023","unstructured":"Gautam, M. et al. Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina. Nat. Commun. 14, 6468 (2023).","journal-title":"Nat. Commun."},{"key":"2711_CR10","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1021\/acs.nanolett.7b02664","volume":"17","author":"S Patel","year":"2017","unstructured":"Patel, S. et al. Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA. Nano Lett. 17, 5711\u20135718 (2017).","journal-title":"Nano Lett."},{"key":"2711_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201807748","volume":"31","author":"K Paunovska","year":"2019","unstructured":"Paunovska, K. et al. Nanoparticles containing oxidized cholesterol deliver mRNA to the liver microenvironment at clinically relevant doses. Adv. Mater. 31, 1807748 (2019).","journal-title":"Adv. Mater."},{"key":"2711_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14527-2","volume":"11","author":"S Patel","year":"2020","unstructured":"Patel, S. et al. Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat. Commun. 11, 983 (2020).","journal-title":"Nat. Commun."},{"key":"2711_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.omtn.2017.11.005","volume":"10","author":"KJ Kauffman","year":"2018","unstructured":"Kauffman, K. J. et al. Rapid, single-cell analysis and discovery of vectored mRNA transfection in vivo with a loxP-flanked tdTomato reporter mouse. Mol. Ther. Nucleic Acids 10, 55\u201363 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2711_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"2711_CR15","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jconrel.2022.03.046","volume":"345","author":"ST LoPresti","year":"2022","unstructured":"LoPresti, S. T., Arral, M. L., Chaudhary, N. & Whitehead, K. A. The replacement of helper lipids with charged alternatives in lipid nanoparticles facilities targeted mRNA delivery to the spleen and lungs. J. Control. Release 345, 819\u2013831 (2022).","journal-title":"J. Control. Release"},{"key":"2711_CR16","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1021\/acs.nanolett.2c04479","volume":"23","author":"A Radmand","year":"2023","unstructured":"Radmand, A. et al. The transcriptional response to lung-targeting lipid nanoparticles in vivo. Nano Lett. 23, 993\u20131002 (2023).","journal-title":"Nano Lett."},{"key":"2711_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06936-1","volume":"9","author":"N Veiga","year":"2018","unstructured":"Veiga, N. et al. Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes. Nat. Commun. 9, 4493 (2018).","journal-title":"Nat. Commun."},{"key":"2711_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.ade6967","volume":"381","author":"L Breda","year":"2023","unstructured":"Breda, L. et al. In vivo hematopoietic stem cell modification by mRNA delivery. Science 381, 436\u2013443 (2023).","journal-title":"Science"},{"key":"2711_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"2711_CR20","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1021\/acs.nanolett.8b00432","volume":"18","author":"K Paunovska","year":"2018","unstructured":"Paunovska, K. et al. A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation. Nano Lett. 18, 2148\u20132157 (2018).","journal-title":"Nano Lett."},{"key":"2711_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13325","volume":"7","author":"Z Yaari","year":"2016","unstructured":"Yaari, Z. et al. Theranostic barcoded nanoparticles for personalized cancer medicine. Nat. Commun. 7, 13325 (2016).","journal-title":"Nat. Commun."},{"key":"2711_CR22","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1073\/pnas.1620874114","volume":"114","author":"JE Dahlman","year":"2017","unstructured":"Dahlman, J. E. et al. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics. Proc. Natl Acad. Sci. USA 114, 2060\u20132065 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2711_CR23","doi-asserted-by":"publisher","first-page":"E9944","DOI":"10.1073\/pnas.1811276115","volume":"115","author":"CD Sago","year":"2018","unstructured":"Sago, C. D. et al. High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing. Proc. Natl Acad. Sci. USA 115, E9944\u2013E9952 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2711_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41565-021-01030-y","volume":"17","author":"MZC Hatit","year":"2022","unstructured":"Hatit, M. Z. C. et al. Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles. Nat. Nanotechnol. 17, 310\u2013318 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"2711_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41565-022-01146-9","volume":"17","author":"C Dobrowolski","year":"2022","unstructured":"Dobrowolski, C. et al. Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery. Nat. Nanotechnol. 17, 871\u2013879 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"2711_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-024-02470-2","author":"H Kim","year":"2024","unstructured":"Kim, H. et al. Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-024-02470-2 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2711_CR27","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences, Engineering and Medicine. Nonhuman Primate Models in Biomedical Research: State of the Science and Future Needs (The National Academies Press, 2023); https:\/\/doi.org\/10.17226\/26857","DOI":"10.17226\/26857"},{"key":"2711_CR28","unstructured":"United States Securities and Exchange Commission Form 8-K. Verve Therapeutics https:\/\/ir.vervetx.com\/static-files\/ff045a43-e13f-4f30-b651-c9946c0055dd (2022)."},{"key":"2711_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06508-3","volume":"9","author":"PM Tiwari","year":"2018","unstructured":"Tiwari, P. M. et al. Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection. Nat. Commun. 9, 3999 (2018).","journal-title":"Nat. Commun."},{"key":"2711_CR30","doi-asserted-by":"publisher","first-page":"7590","DOI":"10.1021\/acs.nanolett.8b03149","volume":"18","author":"CD Sago","year":"2018","unstructured":"Sago, C. D. et al. Modifying a commonly expressed endocytic receptor retargets nanoparticles in vivo. Nano Lett. 18, 7590\u20137600 (2018).","journal-title":"Nano Lett."},{"key":"2711_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","volume":"15","author":"KJ Hassett","year":"2019","unstructured":"Hassett, K. J. et al. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol. Ther. Nucleic Acids 15, 1\u201311 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2711_CR32","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1021\/ja301621z","volume":"134","author":"D Chen","year":"2012","unstructured":"Chen, D. et al. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J. Am. Chem. Soc. 134, 6948\u20136951 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"2711_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2012.28","volume":"1","author":"NM Belliveau","year":"2012","unstructured":"Belliveau, N. M. et al. Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA. Mol. Ther. Nucleic Acids 1, e37 (2012).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2711_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202211420","volume":"35","author":"K Lam","year":"2023","unstructured":"Lam, K. et al. Optimizing lipid nanoparticles for delivery in primates. Adv. Mater. 35, e2211420 (2023).","journal-title":"Adv. Mater."},{"key":"2711_CR35","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.1021\/acsnano.4c09399","volume":"19","author":"M Gao","year":"2025","unstructured":"Gao, M. et al. Deciphering the role of PEGylation on the lipid nanoparticle-mediated mRNA delivery to the liver. ACS Nano 19, 5966\u20135978 (2025).","journal-title":"ACS Nano"},{"key":"2711_CR36","doi-asserted-by":"publisher","first-page":"6743","DOI":"10.1021\/acs.nanolett.4c01458","volume":"24","author":"Z Guo","year":"2024","unstructured":"Guo, Z. et al. Helper lipid-enhanced mRNA delivery for treating metabolic dysfunction-associated fatty liver disease. Nano Lett. 24, 6743\u20136752 (2024).","journal-title":"Nano Lett."},{"key":"2711_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jconrel.2024.08.016","volume":"374","author":"BD Barbieri","year":"2024","unstructured":"Barbieri, B. D. et al. The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNA. J. Control. Release 374, 280\u2013292 (2024).","journal-title":"J. Control. Release"},{"key":"2711_CR38","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41551-023-01131-0","volume":"8","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity. Nat. Biomed. Eng. 8, 544\u2013560 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"2711_CR39","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","volume":"15","author":"KJ Kauffman","year":"2015","unstructured":"Kauffman, K. J. et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett. 15, 7300\u20137306 (2015).","journal-title":"Nano Lett."},{"key":"2711_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cobme.2018.08.001","volume":"7","author":"MP Lokugamage","year":"2018","unstructured":"Lokugamage, M. P., Sago, C. D. & Dahlman, J. E. Testing thousands of nanoparticles in vivo using DNA barcodes. Curr. Opin. Biomed. Eng. 7, 1\u20138 (2018).","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"2711_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s42826-019-0006-0","volume":"35","author":"BS Koo","year":"2019","unstructured":"Koo, B. S. et al. Reference values of hematological and biochemical parameters in young-adult cynomolgus monkey (Macaca fascicularis) and rhesus monkey (Macaca mulatta) anesthetized with ketamine hydrochloride. Lab. Anim. Res. 35, 7 (2019).","journal-title":"Lab. Anim. Res."},{"key":"2711_CR42","first-page":"528","volume":"47","author":"SJ Buchl","year":"1997","unstructured":"Buchl, S. J. & Howard, B. Hematologic and serum biochemical and electrolyte values in clinically normal domestically bred rhesus monkeys (Macaca mulatta) according to age, sex, and gravidity. Lab. Anim. Sci. 47, 528\u2013533 (1997).","journal-title":"Lab. Anim. Sci."},{"key":"2711_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2018","unstructured":"Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37, 38\u201344 (2018).","journal-title":"Nat. Biotechnol."},{"key":"2711_CR44","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"2711_CR45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.addr.2020.06.026","volume":"159","author":"D Witzigmann","year":"2020","unstructured":"Witzigmann, D. et al. Lipid nanoparticle technology for therapeutic gene regulation in the liver. Adv. Drug Deliv. Rev. 159, 344\u2013363 (2020).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2711_CR46","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1172\/JCI1240","volume":"101","author":"A Rohlmann","year":"1998","unstructured":"Rohlmann, A., Gotthardt, M., Hammer, R. E. & Herz, J. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J. Clin. Invest. 101, 689\u2013695 (1998).","journal-title":"J. Clin. Invest."},{"key":"2711_CR47","doi-asserted-by":"publisher","first-page":"10836","DOI":"10.1523\/JNEUROSCI.5065-10.2011","volume":"31","author":"S Ranganathan","year":"2011","unstructured":"Ranganathan, S. et al. LRAD3, a novel low-density lipoprotein receptor family member that modulates amyloid precursor protein trafficking. J. Neurosci. 31, 10836\u201310846 (2011).","journal-title":"J. Neurosci."},{"key":"2711_CR48","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1073\/pnas.76.1.333","volume":"76","author":"JL Goldstein","year":"1979","unstructured":"Goldstein, J. L., Ho, Y. K., Basu, S. K. & Brown, M. S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl Acad. Sci. USA 76, 333\u2013337 (1979).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2711_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37465-1","volume":"14","author":"LN Kasiewicz","year":"2023","unstructured":"Kasiewicz, L. N. et al. GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy. Nat. Commun. 14, 2776 (2023).","journal-title":"Nat. Commun."},{"key":"2711_CR50","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","volume":"35","author":"M Cuchel","year":"2014","unstructured":"Cuchel, M. et al. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur. Heart J. 35, 2146\u20132157 (2014).","journal-title":"Eur. Heart J."},{"key":"2711_CR51","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","volume":"38","author":"M Klichinsky","year":"2020","unstructured":"Klichinsky, M. et al. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat. Biotechnol. 38, 947\u2013953 (2020).","journal-title":"Nat. Biotechnol."},{"key":"2711_CR52","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","volume":"390","author":"H Frangoul","year":"2024","unstructured":"Frangoul, H. et al. Exagamglogene Autotemcel for severe sickle cell disease. N. Engl. J. Med. 390, 1649\u20131662 (2024).","journal-title":"N. Engl. J. Med."},{"key":"2711_CR53","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1126\/science.adk9428","volume":"384","author":"Y Sun","year":"2024","unstructured":"Sun, Y. et al. In vivo editing of lung stem cells for durable gene correction in mice. Science 384, 1196\u20131202 (2024).","journal-title":"Science"},{"key":"2711_CR54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2400783121","volume":"121","author":"R Palanki","year":"2024","unstructured":"Palanki, R. et al. In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cells. Proc. Natl Acad. Sci. USA 121, e2400783121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2711_CR55","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41577-018-0005-7","volume":"18","author":"JD Estes","year":"2018","unstructured":"Estes, J. D., Wong, S. W. & Brenchley, J. M. Nonhuman primate models of human viral infections. Nat. Rev. Immunol. 18, 390\u2013404 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"2711_CR56","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S0140-6736(08)60489-4","volume":"371","author":"JP Capitanio","year":"2008","unstructured":"Capitanio, J. P. & Emborg, M. E. Contributions of non-human primates to neuroscience research. Lancet 371, 1126\u20131135 (2008).","journal-title":"Lancet"},{"key":"2711_CR57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"2711_CR58","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nnano.2014.84","volume":"9","author":"JE Dahlman","year":"2014","unstructured":"Dahlman, J. E. et al. In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. Nat. Nanotechnol. 9, 648\u2013655 (2014).","journal-title":"Nat. Nanotechnol."},{"key":"2711_CR59","doi-asserted-by":"publisher","first-page":"342ra380","DOI":"10.1126\/scitranslmed.aaf1435","volume":"8","author":"HB Sager","year":"2016","unstructured":"Sager, H. B. et al. RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction. Sci. Transl. Med. 8, 342ra380 (2016).","journal-title":"Sci. Transl. Med."},{"key":"2711_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32281-5","volume":"13","author":"H Ni","year":"2022","unstructured":"Ni, H. et al. Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo. Nat. Commun. 13, 4766 (2022).","journal-title":"Nat. Commun."},{"key":"2711_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"2711_CR62","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337 (2019).","journal-title":"Cell Syst."},{"key":"2711_CR63","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865\u2013868 (2017).","journal-title":"Nat. Methods"},{"key":"2711_CR64","doi-asserted-by":"crossref","unstructured":"Zenhausern, R., Kim, H. & Dahlman, J. E. Lipid nanoparticle screening in nonhuman primates with minimal loss of life. Sequence Read Archive https:\/\/www.ncbi.nlm.nih.gov\/bioproject\/PRJNA1214529 (2025).","DOI":"10.1038\/s41587-025-02711-y"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02711-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02711-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02711-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T22:18:07Z","timestamp":1779056287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02711-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2711"],"URL":"https:\/\/doi.org\/10.1038\/s41587-025-02711-y","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.E.D. advises Readout Capital, Edge Animal Health and Nava Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}